These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 31266001)

  • 21. [Phage therapy, an alternative to antibiotic therapy?)].
    Reina J; Reina N
    Rev Esp Quimioter; 2018 Apr; 31(2):101-104. PubMed ID: 29451376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains.
    Rohde C; Resch G; Pirnay JP; Blasdel BG; Debarbieux L; Gelman D; Górski A; Hazan R; Huys I; Kakabadze E; Łobocka M; Maestri A; Almeida GMF; Makalatia K; Malik DJ; Mašlaňová I; Merabishvili M; Pantucek R; Rose T; Štveráková D; Van Raemdonck H; Verbeken G; Chanishvili N
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29621199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
    Manohar P; Nachimuthu R; Lopes BS
    BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational models of populations of bacteria and lytic phage.
    Krysiak-Baltyn K; Martin GJ; Stickland AD; Scales PJ; Gras SL
    Crit Rev Microbiol; 2016 Nov; 42(6):942-68. PubMed ID: 26828960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between the phageome and human health: are bacteriophages beneficial or harmful microbes?
    Fernández L; Duarte AC; Rodríguez A; García P
    Benef Microbes; 2021 Apr; 12(2):107-120. PubMed ID: 33789552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implications of lytic phage infections inducing persistence.
    Sanchez-Torres V; Kirigo J; Wood TK
    Curr Opin Microbiol; 2024 Jun; 79():102482. PubMed ID: 38714140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phage therapy for the treatment of human intestinal bacterial infections: soon to be a reality?
    Brüssow H
    Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):785-788. PubMed ID: 28612636
    [No Abstract]   [Full Text] [Related]  

  • 28. Propagation, Purification, and Characterization of Bacteriophages for Phage Therapy.
    Kosznik-Kwaśnicka K; Topka G; Mantej J; Grabowski Ł; Necel A; Węgrzyn G; Węgrzyn A
    Methods Mol Biol; 2024; 2738():357-400. PubMed ID: 37966610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phage therapy for severe bacterial infections: a narrative review.
    Petrovic Fabijan A; Khalid A; Maddocks S; Ho J; Gilbey T; Sandaradura I; Lin RC; Ben Zakour N; Venturini C; Bowring B; Iredell JR
    Med J Aust; 2020 Apr; 212(6):279-285. PubMed ID: 31587298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naturally-occurring and cultured bacteriophages in human therapy.
    Kiani AK; Anpilogov K; Dhuli K; Paolacci S; Benedetti S; Manara E; Guerri G; Dautaj A; Beccari T; Dundar M; Bertelli M
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(1 Suppl):101-107. PubMed ID: 34890040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy.
    Segall AM; Roach DR; Strathdee SA
    Curr Opin Microbiol; 2019 Oct; 51():46-50. PubMed ID: 31226502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phage Therapy: The Pharmacology of Antibacterial Viruses.
    Danis-Wlodarczyk K; Dąbrowska K; Abedon ST
    Curr Issues Mol Biol; 2021; 40():81-164. PubMed ID: 32503951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combatting intracellular pathogens using bacteriophage delivery.
    Goswami A; Sharma PR; Agarwal R
    Crit Rev Microbiol; 2021 Aug; 47(4):461-478. PubMed ID: 33818246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?
    Maciejewska B; Olszak T; Drulis-Kawa Z
    Appl Microbiol Biotechnol; 2018 Mar; 102(6):2563-2581. PubMed ID: 29442169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phage therapy of wound-associated infections.
    Zyman A; Górski A; Międzybrodzki R
    Folia Microbiol (Praha); 2022 Apr; 67(2):193-201. PubMed ID: 35028881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virulence-associated factors as targets for phage infection.
    de Melo AG; Morency C; Moineau S
    Curr Opin Microbiol; 2024 Jun; 79():102471. PubMed ID: 38569419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Diverse Impacts of Phage Morons on Bacterial Fitness and Virulence.
    Taylor VL; Fitzpatrick AD; Islam Z; Maxwell KL
    Adv Virus Res; 2019; 103():1-31. PubMed ID: 30635074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phages amid antimicrobial resistance.
    Mohan Raj JR; Karunasagar I
    Crit Rev Microbiol; 2019; 45(5-6):701-711. PubMed ID: 31775552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivering phage therapy per os: benefits and barriers.
    Zelasko S; Gorski A; Dabrowska K
    Expert Rev Anti Infect Ther; 2017 Feb; 15(2):167-179. PubMed ID: 27885865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.